CDKN2A and Patent ductus arteriosus: Additionally, mutations in the tumor suppressors p53, p16INK4, and Smad4 occur during the different PanIN stages (Hezel et al. 2006), contributing to the development of more advanced and invasive PDA (Vogelstein and Kinzler 2004).